{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/133487091"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/424707805" ] } },

    { "id" : "http://webisa.webdatacommons.org/424707805"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, and other members of senior management will host a conference call to discuss the FDA approval of EYLEA for the treatment of patients with wet AMD and launch plans, as well as other corporate matters." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "multivu.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/270487954"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/424707805"] } } }
